Terazosin 2mg tablets

Nazione: Regno Unito

Lingua: inglese

Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)

Principio attivo:

Terazosin hydrochloride

Commercializzato da:

Sigma Pharmaceuticals Plc

Codice ATC:

G04CA03

INN (Nome Internazionale):

Terazosin hydrochloride

Dosaggio:

2mg

Forma farmaceutica:

Oral tablet

Via di somministrazione:

Oral

Classe:

No Controlled Drug Status

Tipo di ricetta:

Valid as a prescribable product

Dettagli prodotto:

BNF: 02050400

Foglio illustrativo

306/06
TERAZOSIN 2 MG, 5MG AND 10MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist or
nurse.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Terazosin is and what it is used for
2.
What you need to know before you take Terazosin
3.
How to take Terazosin
4.
Possible side effects
5.
How to store Terazosin
6.
Contents of the pack and other information
1. WHAT TERAZOSIN IS AND WHAT IT IS USED FOR
The name of this medicine is Terazosin 2mg Tablets, Terazosin 5mg
Tablets or Terazosin 10mg
Tablets referred to as Terazosin throughout this leaflet.
Terazosin belongs to a group of medicines called ‘alpha blockers’
which help to relax smooth
muscle and has been prescribed for you to treat one of the following:

Improve the obstructive symptoms caused by benign prostatic
hyperplasia (BPH) and help the
flow of urine from the bladder

Treat mild to moderate hypertension (high blood pressure).
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TERAZOSIN
DO NOT TAKE TERAZOSIN IF:

You are allergic (hypersensitive) to Terazosin or to any of the other
ingredients in this medicine
(listed in Section 6)

You are allergic (hypersensitive) to other medicines in the ‘alpha
blocker’ group.

You have ever fallen over or fainted whilst passing water.
Do not take Terazosin if any of the above apply to you. If you are not
sure, talk to your doctor or
pharmacist before taking this medicine.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Terazosin if you:

Are taking other medication for high blood pressu

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Terazosin 2 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.374 mg of terazosin hydrochloride dihydrate
equivalent
to 2mg of terazosin.
For excipients see 6.1.
3
PHARMACEUTICAL FORM
Tablet
Mottled-yellow,
round,
flat
tablet
with
bevelled
edges, embossed with “93” on one-side and “761”
on the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Terazosin Tablets are indicated for:
The treatment of mild to moderate hypertension.
The symptomatic treatment of urinary obstruction caused by benign
prostatic
hyperplasia (BPH).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use.
For the different dosage regimens suitable strengths are available.
The dose of
terazosin should be adjusted according to the patient's response. The
following
is a guide to administration:
INITIAL DOSE:
The lowest single dose of 1 mg before bedtime for all patients which
should
not be exceeded. Strict compliance with this recommendation should be
observed to minimise potential acute first-dose hypotensive episodes.
SUBSEQUENT DOSES:
Treatment of mild to moderate hypertension.
The single daily dosage may be increased by approximately doubling the
dosage at weekly intervals to achieve the desired blood pressure
response.
The maintenance dose needs to be adjusted to the patient’s response.
2 mg/day
may be sufficient with increases up to 10 mg if necessary (clinical
studies
support the use of 2-10 mg as maintenance dose).
The maximum dose is 20 mg of terazosin per day and should not be
exceeded.
Use with thiazide diuretics and other antihypertensive agents in the
treatment
of hypertension
When adding a thiazide diuretic or another antihypertensive agent to a
patient's
regimen the dose of terazosin should be reduced or discontinued and
retitration
carried out if necessary. Caution should be observed when terazosin is
administered with thiazides or other antihypertensive agents as
hypotension
may develop.
Treatment of benign prostati